LAPTM4B mRNA and/or protein was also overexpressed in a wide variety of cancers such as hepatocellular carcinoma, gallbladder carcinoma, uterine cancer, ovarian cancer, extrahepatic cholangiocarcinoma [4], [19], [20], [21]. This evidence concerns the gene LAPTM4B and ovarian carcinoma.